Nonsteroidal antiinflammatory drugs have been shown to increase the risk for cardiovascular events. In patients with coronary artery disease, current guidelines therefore suggest avoiding such drugs and recommend acetaminophen as the first-line analgesic of choice instead. However, the results of the present prospective study provide the first evidence of a blood pressure elevation in these patients, thus questioning the assumption of the cardiovascular safety of acetaminophen. In view of the established continuous incremental risk of cardiovascular and cerebrovascular disease in relation to blood pressure, an elevation associated with the use of acetaminophen could further increase the risk of myocardial infarction and stroke in patients at high cardiovascular risk or, in particular, in those with established cardiovascular disease. Because the use of acetaminophen is frequent, the blood pressure increase caused by this drug is a potential public health concern. Unless the cardiovascular safety of acetaminophen has been cleared in randomized controlled clinical trials specifically addressing the safety of this agent, the use of acetaminophen should be evaluated as rigorously as all traditional antiinflammatory drugs, particularly in patients at increased cardiovascular risk. See p 1789.
Cardiovascular Effects of 1 Year of Progressive and Vigorous Exercise Training in Previously Sedentary Individuals Older Than 65 Years of Age
Healthy but sedentary aging leads to the stiffening of the heart. For example, the left ventricle (LV) becomes less compliant and LV early diastolic function (relaxation and filling) becomes impaired with aging. Life-long endurance training as seen in Masters athletes can prevent this age-related change in the LV compliance, but only minimally influences age-related impairments in dynamic LV relaxation and filling. In the present study, we prescribed a year of progressive and vigorous exercise training to 9 sedentary individuals older than 65 years of age and evaluated overall cardiac function by use of several modalities, including invasive pressure-volume measurements, exercise testing, cardiac echo-Doppler, and cardiac magnetic resonance imaging before and after the training. To our knowledge, this is the first study to evaluate the effect of exercise training on the LV compliance in sedentary individuals. Unfortunately the hypothesized improvement in LV compliance with training was not observed in this small but carefully studied sample. Nonetheless, the dose of exercise training prescribed induced physiological LV remodeling and imparted favorable effects on arterial function and aerobic exercise capacity, which may have beneficial effects for cardiovascular morbidity and mortality. Further research will elucidate at which age exercise training should be started or how much exercise training (volume and intensity) per week is needed to prevent the age-related change in LV compliance. The present results could constitute an important step for the development of optimal training programs or adjunctive therapies in seniors with and without cardiovascular diseases. See p 1797.
Improved Outcomes With Early Collaborative Care of Ambulatory Heart Failure Patients Discharged From the Emergency Department
Although many heart failure patients visit the emergency department (ED) for care, little is known about the care and outcomes of patients who are discharged from the ED. In this study, we examined the outcomes of heart failure patients who received care by a primary care physician, care by a cardiologist, no physician care, or collaborative care provided by both a primary care physician and cardiologist within 30 days of discharge from the ED. In a propensitymatched analysis, we found that patients who received collaborative care had substantially improved outcomes, with lower risk of death and improved survival free of hospitalizations or repeated ED visits for any cause, compared with those who received care within the first 30 days solely by primary care physicians. Concerningly, of the discharged ED cohort, 19% did not visit any physician within 30 days after discharge. Those who received primary care had reduced mortality and improved heart failure event-free survival compared with those with did not receive early physician care. The processes of care for heart failure examined within 100 days after ED discharge were also significantly improved for those who received collaborative care. The rates of evaluation of left ventricular ejection fraction, noninvasive testing for ischemia detection, and cardiac catheterization were highest among those who received collaborative care. Additionally, the rates of use of beneficial drug therapies were highest in those receiving collaborative care, including those with high-risk characteristics. Access to collaborative care may improve the care and outcomes of heart failure patients who are discharged from the ED. See p 1806.
Association Between Aneurysm Shoulder Stress and Abdominal Aortic Aneurysm Expansion: A Longitudinal Follow-Up Study
By convention, abdominal aortic aneurysm (AAA) diameter has been used as an indicator of the potential risk of rupture. Advances in biomechanics have enabled us to assess the inherent stresses within the aneurysm wall, which are thought to play a role in aneurysm expansion. From the structural view point, aneurysm expansion and rupture results from material fatigue and failure of the aneurysm wall. In this study we assessed the association of AAA wall stresses with their expansion rates and found that stresses at the shoulder of the rapidly expanding aneurysms had good correlation with the expansion rates compared with slowly expanding aneurysms. We also tested the relationship of maximum diameter of the aneurysm to its expansion rate, but although such a relationship is widely believed to exist, we found no such relationship. This highlights the fact that biomechanical stress analysis of AAAs may be useful for estimating their expansion rather than relying only on maximum AAA diameter for assessment of potential risk of rupture. See p 1815.
Modulation of Calcium-Activated Potassium Channels Induces Cardiogenesis of Pluripotent Stem Cells and Enrichment of Pacemaker-Like Cells
It is well accepted that embryonic stem cells represent a particularly attractive source for ex vivo generation of cardiomyocytes. Considering the feasibility of in vitro model systems for pharmacological screenings, toxicological, or even potential cell therapeutic applications, major obstacles need to be overcome. Pharmaceutical model systems require a (1) high purity of the cell system; (2) specifically, differentiated cell subtypes, such as cardiac pacemaker like cells; and (3) absence of unphysiological alterations due to genetically engineered cell genomes. Relative to the future potential for cell
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Original Research Put Into Perspective for the Practicing Clinician Volume 122 Ⅲ Number 18 Ⅲ November 2, 2010 therapeutic applications, furthermore, in vivo improvement of (1) contractile heart function, (2) prevention of arrhythmias caused by insufficient graft guidance, (3) potential teratoma formation, and (4) immunotolerance are the crucial premises. The differentiation system presented here provides an interesting tool for applications in biomedical engineering, pathophysiological, and toxicological studies and even potential therapeutic applications. Here we provide a new cardiac differentiation system exclusive of genetic manipulation and lineage selection and thus fulfilling most of these criteria. See p 1823.
Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis
Atherosclerosis is a chronic inflammatory disease of large arteries with prominent roles of various leukocyte subsets that are recruited from the bloodstream into the vessel wall. Although current dogma emphasizes the role of monocyte and lymphocyte subsets, we describe here a pivotal role for neutrophils in the early stages of atherosclerosis. Hypercholesterolemia is an important risk factor, and we find evidence that high levels of cholesterol induce neutrophilia by cranking up granulopoiesis and by disturbing the chemokine axes regulating neutrophil mobilization from the bone marrow. We further found that levels of circulating neutrophils correlate with the degree of atherosclerosis, which may be useful as a simple approach to cardiovascular risk prediction. In addition, neutrophils infiltrate arteries prominently through the involvement of CCR1, CCR2, CCR5, and CXCR2. The use of CCR1 and CCR5 contrasts to peripheral neutrophil recruitment and may be ascribed to endothelial deposition of CCL5 by platelets. Once emigrated, neutrophils promote atherogenesis, as evidenced by reduced plaque sizes in neutropenic mice. Thus, the use of CCR1 and CCR5 in arterial but not venous recruitment may emerge as a feasible option for therapeutic targeting. Clearly, the addition of the neutrophil as a previously not fully appreciated player in atherosclerosis increases the complexity of cellular interactions in disease pathogenesis but also harbors valuable strategies for prevention and treatment. See p 1837.
Vascular Dysfunction in Women With a History of Preeclampsia and Intrauterine Growth Restriction: Insights Into Future Vascular Risk
Preeclampsia and intrauterine growth restriction can result in devastating pregnancy outcomes. Although initially assumed to be disease entities that resolved quickly postpartum, we are now aware that these pregnancy complications identify women at increased risk for the development of cardiovascular disease. In this study, we examined endothelial function in postpartum women with previous preeclampsia or intrauterine growth restriction, offering a unique approach to in vivo investigation of the early mechanisms of human cardiovascular disease years before the onset of the clinical disease.
Our study is the first to show impaired endothelium-dependent vasodilatation and increased arterial stiffness in women with a previous intrauterine growth restriction pregnancy without preeclampsia. Moreover, we divided preeclamptic women into earlyonset and late-onset disease and showed that women with previous late-onset preeclampsia do not have evidence of vascular dysfunction. These novel findings demonstrating differences in vascular function between these 3 distinct placental diseases provide a pathophysiological explanation for the differential risk for future vascular disease shown in the epidemiological literature. The abnormal vascular physiological profile identified in women with previous early-onset preeclampsia and normotensive intrauterine growth restriction might explain their increased risk of future vascular disease, whereas late-onset preeclampsia may not fall into this high-vascularrisk category. Our study also provides new measures that can be used to identify those women who are at risk for future cardiovascular disease, allowing the investigation of potential therapeutic interventions that may prove beneficial in this high-risk group of women. See p 1846.
Intrinsic Coagulation Activation and the Risk of Arterial Thrombosis in Young Women: Results From the Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Case-Control Study
Arterial forms of thrombosis are leading causes of death and disability in the Western world. The Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study is a populationbased case-control study that focuses on arterial thrombosis in young women (18 to 50 years of age) and has a unique opportunity to identify risk factors that are difficult to identify in older patients because they could be obscured by age-related comorbidities. The identification of these new risk factors could aid in the prevention and treatment of arterial thrombosis in all age groups. This study investigated whether proteins of the intrinsic coagulation pathways are risk factors for arterial thrombosis. Historically, the role of some of these factors was thought to be minor. However, both animal and clinical studies have implicated these proteins in pathophysiological thrombus formation. Furthermore, these proteins also play a role in other relevant biological systems, such as inflammation. Inhibitor complexes of coagulation factors XIIa, Xia, and kallikrein were determined as a measure of protein activation. It was found that these complexes were higher in ischemic stroke cases, but were not higher in myocardial infarction cases, when compared with matched controls. The risk of stroke was further increased (up to 23-fold) among users of oral contraceptives. However, because of the low incidence of arterial thrombosis in young women, screening for these factors before the start of arterial thrombosis does not seem to be warranted. Further studies should be performed to investigate the exact pathophysiological mechanism and whether these mechanisms are different for the subtypes of arterial thrombosis, especially for subtypes of ischemic stroke. See p 1854.
